Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5

Circulation. 2007 Apr 24;115(16):2159-67. doi: 10.1161/CIRCULATIONAHA.106.643536. Epub 2007 Apr 9.

Abstract

Background: Recent cell-based studies have found that cGMP synthesis and hydrolysis by phosphodiesterase (PDE) appear compartmentalized, with nitric oxide synthase-derived and/or PDE type 5 (PDE-5)-hydrolyzable cGMP undetected at the sarcolemmal membrane in contrast to cGMP stimulated by natriuretic peptide. In the present study, we determine the functional significance of such compartments with a comparison of beta-adrenergic modulation by PDE-5 inhibition to that of natriuretic peptide stimulation in both cardiomyocytes and intact hearts. The potential role of differential cGMP and protein kinase G stimulation by these 2 modulators was also studied.

Methods and results: Intact C57/BL6 mouse hearts were studied with pressure-volume analysis, and adult isolated myocytes were studied with fluorescence microscopy. PDE-5 inhibition with 0.1 to 1 micromol/L sildenafil (SIL) suppressed isoproterenol (ISO)-stimulated contractility, whereas 10 micromol/L atrial natriuretic peptide (ANP) had no effect. ISO suppression by SIL was prevented in cells pretreated with a protein kinase G inhibitor. Surprisingly, myocardial cGMP changed little with SIL+ISO yet rose nearly 5-fold with ANP, whereas protein kinase G activation (vasodilator-stimulated protein phosphorylation; ELISA assay) displayed the opposite: increased with SIL+ISO but unaltered by ANP+ISO. PDE-5 and ANP compartments were functionally separated, as inhibition of nitric oxide synthase by N(w)-nitro-L-arginine methyl ester eliminated antiadrenergic effects of SIL, yet this was not restorable by co-stimulation with ANP.

Conclusions: Regulation of cardiac beta-adrenergic response by cGMP is specifically linked to a nitric oxide-synthesis/PDE-5-hydrolyzed pool signaling via protein kinase G. Natriuretic peptide stimulation achieves greater detectable increases in cGMP but not protein kinase G activity and does not modulate beta-adrenergic response. Such disparities likely contribute to differential cardiac regulation by drugs that modulate cGMP synthesis and hydrolysis.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • 3',5'-Cyclic-GMP Phosphodiesterases / physiology*
  • Animals
  • Atrial Natriuretic Factor / pharmacology
  • Cell Compartmentation / physiology
  • Cell Membrane / enzymology
  • Cells, Cultured / drug effects
  • Cells, Cultured / physiology
  • Cyclic GMP / physiology
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / physiology*
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Cytosol / enzymology
  • Enzyme Activation / drug effects
  • Guanylate Cyclase / metabolism
  • Isoproterenol / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology*
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / physiology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / physiology
  • Phosphodiesterase Inhibitors / pharmacology
  • Piperazines / pharmacology*
  • Protein Kinase Inhibitors / pharmacology
  • Purines / pharmacology
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / physiology*
  • Second Messenger Systems / physiology
  • Sildenafil Citrate
  • Sulfones / pharmacology*

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Protein Kinase Inhibitors
  • Purines
  • Receptors, Adrenergic, beta
  • Sulfones
  • Nitric Oxide
  • Atrial Natriuretic Factor
  • Sildenafil Citrate
  • Cyclic GMP-Dependent Protein Kinases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Pde5a protein, mouse
  • Guanylate Cyclase
  • Cyclic GMP
  • Isoproterenol
  • NG-Nitroarginine Methyl Ester